Elevated Hemoglobin and Hematocrit: Evaluation and Management
A hemoglobin of 16.3 g/dL with a hematocrit of 59% represents a significant discordance that requires immediate investigation, as this hematocrit level demands evaluation for polycythemia vera or secondary erythrocytosis, while the hemoglobin value appears only mildly elevated.
Critical Initial Assessment
The reported values show a mathematical inconsistency. Normally, hematocrit should approximate three times the hemoglobin value 1. Here, Hgb 16.3 g/dL would predict Hct ~49%, not 59%. This 10-point discrepancy suggests either:
- Laboratory error or sampling issue (most likely) 2
- Specimen contamination (e.g., IV fluid dilution affecting one measurement) 2
- Different measurement timing or methods
Immediate action: Repeat both measurements from a fresh venipuncture before proceeding with further workup 2.
If Hct 59% is Confirmed
When to Suspect Polycythemia Vera
Assuming the hematocrit of 59% is accurate, this meets criteria for investigating polycythemia vera regardless of the hemoglobin level 3. PV evaluation should be pursued when hematocrit >60% in the absence of obvious hemoconcentration, as red cell mass is almost always increased at this level 3.
The diagnostic algorithm proceeds as follows 3:
Check serum erythropoietin (EPO) level
Bone marrow examination with cytogenetics if EPO is low or normal 3
- Look for hypercellularity, trilineage proliferation, pleomorphic megakaryocytes 3
Revised WHO Diagnostic Criteria for PV
Diagnosis requires both major criteria plus 1 minor criterion, OR first major criterion plus 2 minor criteria 4:
Major Criteria:
- Hemoglobin >16.5 g/dL (men) or >16 g/dL (women), OR Hct >49% (men) or >48% (women) 4, 5
- Presence of JAK2 V617F or exon 12 mutation 4, 5
Minor Criteria:
- Bone marrow biopsy showing hypercellularity with trilineage growth 4
- Serum EPO below reference range 4
- Endogenous erythroid colony formation in vitro 4
Look for PV-Related Features
Even with borderline hematocrit, pursue PV workup if any of these are present 3:
- Thrombocytosis
- Leukocytosis
- Microcytosis from iron deficiency
- Splenomegaly
- Aquagenic pruritus
- Unusual thrombosis (Budd-Chiari syndrome)
- Erythromelalgia
Management Considerations
If PV is Diagnosed
**Target hematocrit <45% through aggressive phlebotomy** 3. Studies show progressive increase in vascular occlusive episodes at hematocrit >44% 3. For women and African Americans, target even lower (42%) due to physiological differences 3.
Critical phlebotomy principles 6:
- Perform with careful fluid replacement to avoid hypotension 3
- Avoid repeated routine phlebotomies - they deplete iron stores, decrease oxygen-carrying capacity, and paradoxically increase stroke risk 6, 7
- Only perform therapeutic phlebotomy when Hgb >20 g/dL AND Hct >65% WITH symptoms of hyperviscosity (headache, fatigue) and no dehydration 6, 7
Special Populations
For cyanotic congenital heart disease patients 8, 6:
- Phlebotomy reasonable when Hct >65% with hyperviscosity symptoms 8
- Phlebotomy reasonable before noncardiac surgery when Hct >65% 8
- Do NOT perform phlebotomy if Hgb <20 g/dL or Hct <65% without symptoms 8
Common Pitfalls
Assuming hemoglobin and hematocrit always correlate - they frequently don't, especially in disease states 1, 9, 2
Over-phlebotomizing - This is the most common error and causes iron deficiency, microcytosis, decreased RBC deformability, and increased stroke risk 6, 7
Missing secondary causes - Always exclude hypoxia, sleep apnea, smoking, renal tumors, testosterone therapy 3, 10
Ignoring the clinical context - A Hct of 59% may be physiologically normal at high altitude (>4000m) where normal ranges extend to 61% in men 11
Not checking for dehydration first - Simple volume depletion can elevate hematocrit without true polycythemia 6